Portland, ORNCT07923045Now EnrollingIRB Ready

Neurotrophic Keratopathy Clinical Trial in Portland, OR

Access cutting-edge neurotrophic keratopathy treatment through this phase 1/2 clinical trial at a research site in Portland. Study-provided care at no cost to qualified participants.

Sponsored by Viatris Inc.

Quick Self-Assessment

See if you qualify for this Portland location

Preparing your pre-screening questions…

Expert Care in Portland

Access neurotrophic keratopathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related neurotrophic keratopathy treatment provided free

Apply for This Portland Location

Check if you qualify for this neurotrophic keratopathy clinical trial in Portland, OR

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Portland

    Convenient for OR residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Portland site if eligible
  4. 4Begin participation

About This Neurotrophic Keratopathy Study in Portland

The objective of this study is to evaluate the safety, tolerability, and biologically effective dose (BED) of MR-146 for the treatment of Stage 1 and Stage 2 Neurotrophic Keratopathy (NK)

Sponsor: Viatris Inc.

Who Can Participate

Inclusion Criteria

Be ≥18 years or greater of age at Visit 1.
Have a diagnosis of Stage 1 or Stage 2 in the study eye for Part 1 or Stage 2 NK in the study eye for Part 2.
Willing and able to participate in and attend to all study visits over the course of 12-14 months

Exclusion Criteria

Have Stage 2 NK affecting both eyes, or Stage 3 NK in either eye.
Any active ocular infections or active ocular inflammation not related to NK in the affected eye.
Have a systemic condition or disease not stabilized or judged by the Investigator to be incompatible with participation in the study
Have monocular vision in the study eye or have BSCVA less than 20/100 in the fellow eye.
Any neurodegenerative disease (example: Parkinson's, Alzheimer's, Multiple Sclerosis, etc)
Uncontrolled glaucoma in either eye.
Any plan to use therapeutic contact lenses.
Anyone pregnant, nursing, or planning to become pregnant within 3 months of participating in the study.
History of incisional conjunctival surgery in the study eye.
History of any ocular surgery in the affected eye within the last 3 months
Botox use in the face or orbital area and/or lacrimal gland within the last 6 months.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Portland?

Yes, this clinical trial (NCT07923045) has an active research site in Portland, OR that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Neurotrophic Keratopathy Treatment Options in Portland, OR

If you're searching for neurotrophic keratopathy treatment options in Portland, OR, this clinical trial (NCT07923045) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Portland research site is actively enrolling participants for this phase 1/2 clinical trial. You'll receive care from experienced neurotrophic keratopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all neurotrophic keratopathy clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Portland, OR

See all rheumatoid arthritis clinical trials recruiting in Portland — not just this study.

Browse Rheumatoid Arthritis Trials in Portland →

Ready to Join in Portland?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Portland, OR